“Vitamin D3: Appears to Fight Prostate Cancer”
About one man in seven will be diagnosed with prostate cancer during his lifetime and the average age at the time of diagnosis is about 66. After skin cancer, prostate cancer is the most common cancer among men in the US. In the US, estimates suggest that during 2016, there will be around 180,890 new cases of prostate cancer and about 26,120 deaths from the disease. Prostate cancer normally affects men over the age of 50. It is the second most common cancer in men worldwide. Two thirds of cases are diagnosed in more developed regions of the world. How long a man with prostate cancer survives appears to be directly influenced by the organ site to which the cancer has spread. This is the conclusion of a new study published in The Journal of Clinical Oncology. Men whose cancer had spread to the lymph nodes only had the longest median survival, at 32 months, while those whose cancer had spread to the liver had the shortest median survival, at 14 months.
